| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.936 | 31.054 | 40.514 | 96.661 | 33.518 |
| Total Income - EUR | - | - | - | - | - | 4.936 | 31.054 | 40.515 | 96.662 | 33.520 |
| Total Expenses - EUR | - | - | - | - | - | 1.299 | 14.799 | 22.906 | 44.182 | 49.074 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.637 | 16.255 | 17.609 | 52.480 | -15.554 |
| Net Profit/Loss - EUR | - | - | - | - | - | 3.490 | 15.945 | 17.204 | 43.943 | -15.554 |
| Employees | - | - | - | - | - | 0 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Novolab Grant Consulting S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 2.122 | 2.414 |
| Current Assets | - | - | - | - | - | 3.971 | 17.992 | 21.060 | 56.298 | 27.419 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.001 | 14.789 | 15.689 | 18.951 | 730 |
| Cash | - | - | - | - | - | 2.970 | 3.203 | 5.371 | 37.347 | 26.690 |
| Shareholders Funds | - | - | - | - | - | 3.532 | 15.993 | 18.412 | 45.149 | 5.273 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 439 | 1.998 | 2.647 | 13.271 | 24.561 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Novolab Grant Consulting S.r.l.